(Q35726340)

9 August 2017

1 reference

title

Multiple sclerosis and vitamin D: an update (English)

1 reference

9 August 2017

0 references

0 references

VanAmerongen BM

1

1 reference

9 August 2017

Dijkstra CD

series ordinal

2

1 reference

9 August 2017

Lips P

series ordinal

3

1 reference

9 August 2017

Polman CH

series ordinal

4

1 reference

9 August 2017

1 August 2004

1 reference

European Journal of Clinical Nutrition

9 August 2017

1 reference

9 August 2017

58

1 reference

9 August 2017

8

1 reference

9 August 2017

1095-1109

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.ejcn.1601952

9 August 2017

0 references

cites work

Isolation and structural identification of 1,25-dihydroxyvitamin D3 produced by cultured alveolar macrophages in sarcoidosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

Diet and the geographical distribution of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

Rat oligodendrocytes express the vitamin D(3) receptor and respond to 1,25-dihydroxyvitamin D(3).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

Vitamin D and its major metabolites: serum levels after graded oral dosing in healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

Vitamin D3 and calcium to prevent hip fractures in elderly women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

Prevalence of vitamin D insufficiency in an adult normal population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

Ultraviolet irradiation corrects vitamin D deficiency and suppresses secondary hyperparathyroidism in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

Increased skin pigment reduces the capacity of skin to synthesise vitamin D3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

Genetic epidemiology of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

Increased 25-hydroxyvitamin D3 1alpha-hydroxylase and reduced 25-hydroxyvitamin D3 24-hydroxylase expression in parathyroid tumors--new prospects for treatment of hyperparathyroidism with vitamin d.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

Fracture history and bone loss in patients with MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

Vitamin D: its role and uses in immunology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

The role of genetic factors in multiple sclerosis susceptibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

Calcitroic acid: biological activity and tissue distribution studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

Vitamin D3 and brain development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

Mortality from multiple sclerosis and exposure to residential and occupational solar radiation: a case-control study based on death certificates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

1,25-Dihydroxyvitamin D3 inhibits the expression of inducible nitric oxide synthase in rat central nervous system during experimental allergic encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

Expression of inducible nitric oxide synthase during rat brain inflammation: regulation by 1,25-dihydroxyvitamin D3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

New clues about vitamin D functions in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

Expression of CYP27A, a gene encoding a vitamin D-25 hydroxylase in human liver and kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

Multiple sclerosis: decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

Dendritic cell modulation by 1alpha,25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

The age-range of risk of developing multiple sclerosis: evidence from a migrant population in Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

Vitamin D as a cytokine and hematopoetic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

1alpha-Hydroxylase and the action of vitamin D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

Vitamin D: the underappreciated D-lightful hormone that is important for skeletal and cellular health

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

Molecular mechanism of vitamin D receptor action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

Seasonal variation in immune measurements and MRI markers of disease activity in MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

The metabolism and mechanism of action of 1,25-dihydroxyvitamin D3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

Diet and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

1,25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

1,25-Dihydroxy-24-OXO-16ene-vitamin D3, a renal metabolite of the vitamin D analog 1,25-dihydroxy-16ene-vitamin D3, exerts immunosuppressive activity equal to its parent without causing hypercalcemia in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

Redefining vitamin D insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

Cytokine profile in patients with multiple sclerosis following vitamin D supplementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

Interactions of 1,25-dihydroxyvitamin D3 and the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

The coming of age of 1,25-dihydroxyvitamin D(3) analogs as immunomodulatory agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

In vitro and in vivo analysis of the immune system of vitamin D receptor knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

Sunscreens suppress cutaneous vitamin D3 synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

The benign form of multiple sclerosis. A study based on 241 cases seen within three years of onset and followed up until the tenth year or more of the disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

Differences in vitamin D status between countries in young adults and the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

The vitamin D receptor is necessary for 1alpha,25-dihydroxyvitamin D(3) to suppress experimental autoimmune encephalomyelitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

An ecologic study of geographical variation in multiple sclerosis risk in central Sardinia, Italy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

A review of the aetiology of multiple sclerosis: an ecological approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

Rag-1-dependent cells are necessary for 1,25-dihydroxyvitamin D(3) prevention of experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

1,25 Dihydroxyvitamin D3 exerts regional effects in the central nervous system during experimental allergic encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

Synthesis of 1,25-dihydroxyvitamin D3 by rat brain macrophages in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

1,25(OH)2-vitamin D3, a steroid hormone that produces biologic effects via both genomic and nongenomic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

Epidemiology of multiple sclerosis in U.S. veterans: 2. Latitude, climate and the risk of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

Progress in determining the causes and treatment of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

Identification and immune regulation of 25-hydroxyvitamin D-1-alpha-hydroxylase in murine macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

Vitamin D3 receptors: structure and function in transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

Ultraviolet radiation and autoimmune disease: insights from epidemiological research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

Multiple sclerosis prevalence among Sardinians: further evidence against the latitude gradient theory

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

Early prediction of a benign course of multiple sclerosis on clinical grounds: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

The role of the vitamin D endocrine system in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

Aggravation of experimental allergic encephalomyelitis (EAE) by administration of nitric oxide (NO) synthase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

Lower serum 25-hydroxyvitamin D is associated with increased bone resorption markers and lower bone density at the proximal femur in normal females: a population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

The 25-hydroxyvitamin D 1-alpha-hydroxylase gene maps to the pseudovitamin D-deficiency rickets (PDDR) disease locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

Factors in human vitamin D nutrition and in the production and cure of classical rickets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

Pathogenesis of tissue injury in MS lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

Regional variation in multiple sclerosis prevalence in Australia and its association with ambient ultraviolet radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

Combination of a 1,25-dihydroxyvitamin D3 analog and a bisphosphonate prevents experimental autoimmune encephalomyelitis and preserves bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

The role of sunlight in the cutaneous production of vitamin D3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

The multifunctional properties and characteristics of vitamin D-binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

Our shifting understanding of the role of nitric oxide in autoimmune encephalomyelitis: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

Seasonal variations in vitamin D status and calcium absorption do not influence bone turnover in young women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

Molecular epidemiology of vitamin D receptor gene variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

SPECIFIC HIGH-AFFINITY RECEPTORS FOR 1,25-DIHYDROXYVITAMIN D3IN HUMAN PERIPHERAL BLOOD MONONUCLEAR CELLS: PRESENCE IN MONOCYTES AND INDUCTION IN T LYMPHOCYTES FOLLOWING ACTIVATION

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

Hypovitaminosis D in Medical Inpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

Sunlight Regulates the Cutaneous Production of Vitamin D3by Causing Its Photodegradation*

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

Genetics and multiple sclerosis: An overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

Effects of seasons on magnetic resonance imaging-measured disease activity in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

Some comments on the relationship of the distribution of multiple sclerosis to latitude, solar radiation, and other variables

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

7 January 2021

Multiple sclerosis and nutrition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

7 January 2021

Seasonal fluctuations of gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

7 January 2021

Vitamin D status in the elderly: seasonal substrate deficiency causes 1,25-dihydroxycholecalciferol deficiency

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

7 January 2021

Prevention of murine experimental allergic encephalomyelitis: cooperative effects of cyclosporine and 1 α, 25-(OH)2D3

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

7 January 2021

Synergism between sirolimus and 1,25-dihydroxyvitamin D3 in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

7 January 2021

Dietary calcium is a major factor in 1,25-dihydroxycholecalciferol suppression of experimental autoimmune encephalomyelitis in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

7 January 2021

Immunomodulatory effects of 1,25-dihydroxyvitamin D3.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

7 January 2021

Absence of seasonal variation in serum concentrations of 1,25-dihydroxyvitamin D despite a rise in 25-hydroxyvitamin D in summer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

7 January 2021

A catalyst of peroxynitrite decomposition inhibits murine experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

7 January 2021

Plasma calcidiol, season, and serum parathyroid hormone concentrations in healthy elderly men and women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

7 January 2021

Seasonal deficiency of vitamin D in children: a potential target for osteoporosis-preventing strategies?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

7 January 2021

Vitamin D and seasonal fluctuations of gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

1 reference

7 January 2021

Association of vitamin D receptor gene polymorphism with multiple sclerosis in Japanese

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

7 January 2021

Treatment of experimental autoimmune encephalomyelitis in rat by 1,25-dihydroxyvitamin D3 leads to early effects within the central nervous system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

7 January 2021

Vitamin D deficiency in homebound elderly persons

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

7 January 2021

Comparison of the biochemical and hormonal acute effects of calcium salts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

7 January 2021

Vitamin D status during puberty in French healthy male adolescents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

7 January 2021

Vitamin D and multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

7 January 2021

Long-latency deficiency disease: insights from calcium and vitamin D

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

7 January 2021

Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

7 January 2021

Seasonal variation in serum 25-hydroxy vitamin D3 does not affect 1,25-dihydroxy vitamin D

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

7 January 2021

Carbon monoxide--does fetal exposure cause sudden infant death syndrome?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

7 January 2021

Expression of vitamin D3 25-hydroxylase (CYP27) mRNA after induction by vitamin D3 or UVB radiation in keratinocytes of human skin equivalents--a preliminary study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

7 January 2021

1,25-Dihydroxyvitamin D3 inhibits the passive transfer of cellular immunity by a myelin basic protein-specific T cell clone

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

7 January 2021

Histomorphometric profile and vitamin D status in patients with femoral neck fracture

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

7 January 2021

The Effect of Vitamin D Supplementation on Vitamin D Status and Parathyroid Function in Elderly Subjects*

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

7 January 2021

Inhibition of Th1 development and treatment of chronic-relapsing experimental allergic encephalomyelitis by a non-hypercalcemic analogue of 1,25-dihydroxyvitamin D(3)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

7 January 2021

Viruses and multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

7 January 2021

1,25-dihydroxyvitamin D3 treatment decreases macrophage accumulation in the CNS of mice with experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

7 January 2021

Vitamin D status: effects on parathyroid hormone and 1, 25-dihydroxyvitamin D in postmenopausal women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

7 January 2021

High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

7 January 2021

No association of vitamin D-binding protein gene polymorphisms in Japanese patients with MS

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

7 January 2021

1,25-Dihydroxyvitamin D3Receptors in Human Leukocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

7 January 2021

1,25-Dihydroxyvitamin D3 induces nitric oxide synthase and suppresses growth of Mycobacterium tuberculosis in a human macrophage-like cell line

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

7 January 2021

Prevalence of subclinical vitamin D deficiency in different European countries

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

7 January 2021

Treatment of multiple sclerosis with low-fat diet

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

7 January 2021

Analogs of 1,25-dihydroxyvitamin D3 as dose-reducing agents for classical immunosuppressants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

7 January 2021

Cell biology of autoimmune diseases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

7 January 2021

Recent developments in the use of vitamin D analogues

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

7 January 2021

Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

7 January 2021

Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

7 January 2021

Decreased bioavailability of vitamin D in obesity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

7 January 2021

Positive and negative modulation of vitamin D receptor function by transforming growth factor-beta signaling through smad proteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

7 January 2021

Convergence of transforming growth factor-beta and vitamin D signaling pathways on SMAD transcriptional coactivators

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

7 January 2021

Experimental allergic encephalomyelitis in the rat is inhibited by aminoguanidine, an inhibitor of nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601952

7 January 2021

Identifiers

DOI

10.1038/SJ.EJCN.1601952

1 reference

9 August 2017

1 reference